5 Panel Drug Test, Abo, NM
If you need a 5 panel drug test in Abo, NM, Accredited Drug Testing Inc has multiple drug testing centers located in Abo, NM and throughout the local area. Same day service is available and most testing centers are within minutes of your home or office.
In addition, to our 5 panel drug test, our Abo, NM drug testing centers also provide 10 panel, 12 panel, 14 panel and 17 panel drug screenings utilizing urine, hair and oral saliva as testing methods. Alcohol testing including ETG and breath alcohol testing is also available.
The 5 panel drug test is the test which is used by the Department of Transportation (DOT) for all modes and it is the most common drug test used by employers who have a Drug Free Workplace Program.
What is the New DOT 5 panel Drug Test?
On January 1, 2018 the Department of Transportation updated its 5-panel drug test. Employers and safety sensitive individuals should also be aware that DOT Drug Testing at HHS-certified laboratories is a 5-panel drug test procedure. As of January 1, 2018, the ‘Opiates’ category was renamed ‘Opioids’:
- Marijuana (THC)
- Phencyclidine (PCP)
Under ‘Opioids’, previously ‘Opiates’, DOT testing will continue to include confirmatory testing, when appropriate, for Codeine, Morphine, and 6-AM (heroin).
We added initial and confirmatory testing for the semi-synthetic opioids Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone to this Opioids group. Some brand names for the semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.
Under Amphetamines, DOT testing includes confirmatory testing, when appropriate, for Amphetamine, Methamphetamine, MDMA, and MDA. To this Amphetamines group, we added initial testing for MDA and removed testing for MDEA.
Since January 1st, we have required confirmation testing for 14 drugs under a 5-panel test. Broken out, here is what DOT drug testing looks like:
- Marijuana (THC)
- 6-AM (heroin)
Both a standard 5 panel drug test or a 5 panel + Expanded Opiates drug test is available when scheduling. A 5 panel drug test can be conducted utilizing urine or hair follicles.
The 5 panel drug test Abo, NM service is commonly used for court, school programs, internships, employment or by employers who utilize a 5 panel drug test as part of a drug free workplace. The 5 panel drug test is becoming a more common drug test for individuals and employers wishing to screen for prescription drugs in addition to common street drugs.
The 5 panel drug test Abo, NM service can also have additional screens added including expanded opiates, which will cover 7 additional opiate drug classifications.
A standard 5 panel drug test Abo, NM service screens for the following drugs
- Phencyclidine (PCP)
- Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them.
- Between 8 and 12 percent develop an opioid use disorder.
- An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.
- About 80 percent of people who use heroin first misused prescription opioids.
- Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.
- The Midwestern region saw opioid overdoses increase 70 percent from July 2016 through September 2017.
- Opioid overdoses in large cities increase by 54 percent in 16 states.
A 5-panel drug test Abo, NM service with expanded opiates screens for these additional drugs,
Accredited Drug Testing Inc offers a 5 panel drug test Abo, NM service and 5 panel + expanded opiates drug test which is analyzed by a SAMHSA Certified Laboratory and reviewed by a Medical Review Officer (MRO). Negative results are typically available within 24-48hrs.
Accredited Drug Testing Inc also offers a 5 panel drug test Abo, NM service with rapid results which provide negative results the same day. Non-negative results will be sent to the laboratory for confirmation testing.
What is an instant drug test?
An instant drug test is a test administered at a drug testing facility in which the specimen is tested by the technician using a dipstick or other type of immediate analysis process. Instant tests are very sensitive and should not be used for court ordered or any disciplinary action against an employee. The results of an instant test in which the test is non-negative should always be sent to a SAMHSA certified laboratory for confirmation testing. An example of the sensitivity of an instant test would be a person taking a completely legal diet pill as part of a weight loss program, but the instant test reports a positive result for amphetamines when a laboratory analysis may not do so. Any time an instant test has a positive result for any drug screened in the specimen should be sent to a certified laboratory for confirmation testing and verification by a Medical Review Officer.
The Opioid Overdose Crisis
Every day, more than 130 people in the United States die after overdosing on opioids. The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement
In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.3,4 Opioid overdose rates began to increase. In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1That same year, an estimated 1.7 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 652,000 suffered from a heroin use disorder (not mutually exclusive)
Accredited Drug Testing Inc is pleased to provide a 5 panel drug test Abo, NM service. To schedule a 5 panel drug test Abo, NM, Call (800)221-4291 or online.
For information on drug testing in the private and public sector – CLICK HERE
For more information on drug and alcohol addiction – CLICK HERE
Local Area Info: ABO (gene)
Histo-blood group ABO system transferase is an enzyme with glycosyltransferase activity, which is encoded by the ABO gene in humans. It is ubiquitously expressed in many tissues and cell types. ABO determines the ABO blood group of an individual by modifying the oligosaccharides on cell surface glycoproteins. Variations in the sequence of the protein between individuals determine the type of modification and the blood group. The ABO gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.
The ABO gene resides on chromosome 9 at the band 9q34.2 and contains 7 exons. The ABO locus encodes three alleles. The A allele produces ?-1,3-N-acetylgalactosamine transferase (A-transferase), which catalyzes the transfer of GalNAc residues from the UDP-GalNAc donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into A antigen in A and AB individuals. The B allele encodes ?-1,3-galactosyl transferase (B-transferase), which catalyzes the transfer of Gal residues from the UDP-Gal donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into B antigen in B and AB individuals. Remarkably, the difference between the A and B glycosyltransferase enzymes is only four amino acids. The O allele lacks both enzymatic activities because of the frame shift caused by a deletion of guanine-258 in the gene which corresponds to a region near the N-terminus of the protein.This results in a frameshift and translation of an almost entirely different protein. This mutation results in a protein unable to modify oligosaccharides which end in fucose linked to galactose. Thus no A or B antigen is found in O individuals. This sugar combination is termed the H antigen. These antigens play an important role in the match of blood transfusion and organ transplantation. Other minor alleles have been found for this gene.
In human cells, the ABO alleles and their encoded glycosyltransferases have been described in several oncologic conditions. Using anti-GTA/GTB monoclonal antibodies, it was demonstrated that a loss of these enzymes was correlated to malignant bladder and oral epithelia. Furthermore, the expression of ABO blood group antigens in normal human tissues is dependent the type of differentiation of the epithelium. In most human carcinomas, including oral carcinoma, a significant event as part of the underlying mechanism is decreased expression of the A and B antigens. Several studies have observed that a relative down-regulation of GTA and GTB occurs in oral carcinomas in association with tumor development. More recently, a genome wide association study (GWAS) has identified variants in the ABO locus associated with susceptibility to pancreatic cancer.